Wednesday, January 13, 2021 7:26:30 AM
AMRX is a good long term hold.
LET'S ALL MAKE SOME $$$$$$$
Recent AMRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/12/2026 08:10:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 10:56:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:28:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:27:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:26:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2026 08:24:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:22:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:15:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:09:04 PM
- Amneal Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/07/2026 08:01:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/27/2026 08:12:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:18:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 09:00:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:26:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:24:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 08:23:25 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 10:24:08 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 10:22:26 AM
- Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader • Business Wire • 04/22/2026 10:17:00 AM
- Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance • GlobeNewswire Inc. • 04/22/2026 10:00:00 AM
- Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY® • GlobeNewswire Inc. • 04/20/2026 12:00:00 PM
- Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S. • GlobeNewswire Inc. • 04/14/2026 12:00:00 PM
- Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% • GlobeNewswire Inc. • 04/09/2026 12:00:00 PM
- Amneal to Report First Quarter 2026 Results on May 1, 2026 • GlobeNewswire Inc. • 04/07/2026 08:01:00 PM
